» Articles » PMID: 39776739

The Impact of Brain Tumors on Emotional and Behavioral Functioning

Overview
Journal Cureus
Date 2025 Jan 8
PMID 39776739
Authors
Affiliations
Soon will be listed here.
Abstract

While the physical manifestations of brain tumors are well-documented, their impact on the emotional and psychological landscape of patients is of equal importance. Patients frequently experience a range of challenges from depression, apathy, and increased aggression to personality changes. The complexity of these changes and their effects on emotional functioning are shaped by tumor characteristics, including location, growth rate, and the corresponding hormonal imbalances. These challenges may ripple outward, affecting not only the patients themselves but also their caregivers. This review aims to examine the diverse emotional experiences associated with various brain tumor types and locations, through understanding the neurobiological mechanisms underlying these changes. The impact of psychosocial factors on emotional distress and coping strategies is also explored, focusing on the critical role of social support and resilience. The need for integrated care that addresses both the physical and psychological aspects of brain tumors is essential for improving the quality of life (QoL) for patients and their families. The close relationship between emotional and cognitive difficulties is analyzed, stressing how these challenges can mutually reinforce each other, creating a convoluted and challenging situation for brain tumor patients. By understanding and addressing these issues, healthcare providers can better support patients and improve their overall QoL. This review seeks to consolidate the current understanding of this complicated relationship, drawing from an array of studies, reviews, and meta-analyses.

References
1.
Turpyn C, Poon J, Ross C, Thompson J, Chaplin T . Associations Between Parent Emotional Arousal and Regulation and Adolescents' Affective Brain Response. Soc Dev. 2018; 27(1):3-18. PMC: 5880048. DOI: 10.1111/sode.12263. View

2.
Rottgering J, Douw L, de Witt Hamer P, Kouwenhoven M, Wurdinger T, van de Ven P . Reducing severe fatigue in patients with diffuse glioma: a study protocol for an RCT on the effect of blended cognitive behavioural therapy. Trials. 2022; 23(1):568. PMC: 9287927. DOI: 10.1186/s13063-022-06485-5. View

3.
de la Cruz F, Wagner G, Schumann A, Suttkus S, Gullmar D, Reichenbach J . Interrelations between dopamine and serotonin producing sites and regions of the default mode network. Hum Brain Mapp. 2020; 42(3):811-823. PMC: 7814772. DOI: 10.1002/hbm.25264. View

4.
Armstrong T, Bishof A, Brown P, Klein M, Taphoorn M, Theodore-Oklota C . Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report. Neuro Oncol. 2016; 18 Suppl 2:ii1-ii12. PMC: 4795996. DOI: 10.1093/neuonc/nov267. View

5.
Facchini S, Favaretto C, Castellaro M, Zangrossi A, Zannin M, Bisogno A . A common low dimensional structure of cognitive impairment in stroke and brain tumors. Neuroimage Clin. 2023; 40:103518. PMC: 10562193. DOI: 10.1016/j.nicl.2023.103518. View